<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The patient was initially diagnosed as having non-Hodgkin's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> and was cured following treatment with <z:chebi fb="2" ids="8378">prednisolone</z:chebi>, <z:chebi fb="0" ids="28445">vincristine</z:chebi>, <z:chebi fb="0" ids="41977">daunorubicin</z:chebi>, 1-asparaginase, and <z:chebi fb="0" ids="4027">cyclophosphamide</z:chebi> </plain></SENT>
<SENT sid="1" pm="."><plain>Seven years and two months later, he developed <z:hpo ids='HP_0002669'>osteosarcoma</z:hpo> in his right femur </plain></SENT>
<SENT sid="2" pm="."><plain>He received chemotherapy consisting of <z:chebi fb="0" ids="44185">methotrexate</z:chebi>, <z:chebi fb="2" ids="31355">carboplatin</z:chebi>, <z:chebi fb="0" ids="4911">etoposide</z:chebi>, and ifosfamide and again obtained remission </plain></SENT>
<SENT sid="3" pm="."><plain>After 2 years and 7 months, however, he was found to have <z:hpo ids='HP_0001876'>pancytopenia</z:hpo> with morphological abnormalities in the erythroid and myeloid series </plain></SENT>
<SENT sid="4" pm="."><plain>Diagnosis of <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>) was made </plain></SENT>
<SENT sid="5" pm="."><plain>Cytogenetic analysis of bone marrow cells revealed -5 and -7, which is typical for <z:e sem="disease" ids="C0280745" disease_type="Neoplastic Process" abbrv="">secondary MDS</z:e> </plain></SENT>
<SENT sid="6" pm="."><plain>This is a rare case of third <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">malignancy</z:e> presumably caused by <z:chebi fb="0" ids="22333">alkylating agents</z:chebi> </plain></SENT>
</text></document>